Mother-to-child transmission of HIV-1 in the era prior to the availability of combination antiretroviral therapy: The role of drugs of abuse (Q37858073)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 31, 2011

Language	Label	Description	Also known as
English	Mother-to-child transmission of HIV-1 in the era prior to the availability of combination antiretroviral therapy: The role of drugs of abuse	scientific article published on March 31, 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

1 reference

Europe PubMed Central

Mother-to-child transmission of HIV-1 in the era prior to the availability of combination antiretroviral therapy: the role of drugs of abuse (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Mother-to-child transmission of HIV-1 in the era prior to the availability of combination antiretroviral therapy: The role of drugs of abuse (English)

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

HIV transmission

0 references

anti-retroviral agent

0 references

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21439978

28 November 2024

vertically transmitted infection

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21439978

28 November 2024

author name string

Russell B. Van Dyke

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21439978

28 November 2024

language of work or name

0 references

publication date

31 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

full work available at URL

https://api.elsevier.com/content/article/PII:S0024320511001305?httpAccept=text/xml

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

https://api.elsevier.com/content/article/PII:S0024320511001305?httpAccept=text/plain

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

88

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

21-22

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

922-925

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Risk factors for mother-to-child transmission of HIV-1

1

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Sexual Behavior and Injection Drug Use During Pregnancy and Vertical Transmission of HIV-1

3

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Influence of other maternal variables on the relationship between maternal virus load and mother-to-infant transmission of human immunodeficiency virus type 1.

4

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Self-reported antiretroviral therapy in injection drug users.

5

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Cocaine using during pregnancy and low birth weight: the impact of prenatal care and drug treatment

7

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group

8

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission

9

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Birth order, delivery route, and concordance in the transmission of human immunodeficiency virus type 1 from mothers to twins. International Registry of HIV-Exposed Twins

10

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group

11

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study

13

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Morphine Enhances HIV Infection of Neonatal Macrophages

14

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Risk factors for in utero and intrapartum transmission of HIV.

15

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Recent trends in the incidence and morbidity that are associated with perinatal human immunodeficiency virus infection in the United States

16

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team.

17

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women

18

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Short-term discontinuation of HAART regimens more common in vulnerable patient populations

19

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission.

20

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group

21

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

μ-opioid modulation of HIV-1 coreceptor expressionand HIV-1 replication

22

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Barriers to use of free antiretroviral therapy in injection drug users

24

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Breastfeeding, genetic, obstetric and other risk factors associated with mother-to-child transmission of HIV-1 in Sao Paulo State, Brazil. Sao Paulo Collaborative Study for Vertical Transmission of HIV-1.

26

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

The Ariel Project: A prospective cohort study of maternal-child transmission of human immunodeficiency virus type 1 in the era of maternal antiretroviral therapy

27

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users

28

1 reference

10.1016/J.LFS.2011.03.006

https://api.crossref.org/works/10.1016/J.LFS.2011.03.006

28 November 2024

Identifiers

10.1016/J.LFS.2011.03.006

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37858073&oldid=2280681820"